Association of noninvasiveventilation strategies withmortality and bronchopulmonarydysplasiaamong preterm infants: A systematic review and meta-analysis

JAMA - Journal of the American Medical Association

Volumn 316, Issue 6, 2016, Pages 611-624

  Isayama, Tetsuya ^a,b   Iwami, Hiroko ^c   McDonald, Sarah ^a   Beyene, Joseph ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

BRAIN HEMORRHAGE; CONFERENCE PAPER; HUMAN; INFANT MORTALITY; INTERMETHOD COMPARISON; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTUBATION; LUNG DYSPLASIA; META ANALYSIS; NEBULIZATION; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; BAYES THEOREM; BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; COMPARATIVE STUDY; ENDOTRACHEAL INTUBATION; GESTATIONAL AGE; INFANT; LARYNGEAL MASK; NEWBORN; ODDS RATIO; PROCEDURES; PUBLISHING;

BAYES THEOREM; BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; CONTINUOUS POSITIVE AIRWAY PRESSURE; GESTATIONAL AGE; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INTERMITTENT POSITIVE-PRESSURE BREATHING; INTUBATION, INTRATRACHEAL; LARYNGEAL MASKS; NONINVASIVE VENTILATION; ODDS RATIO; PUBLICATION BIAS; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84981263326     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.10708     Document Type: Conference Paper

References (71)

1. Murray CJ, Atkinson C, Bhalla K, et al; US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591-608.
2. Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129(6):1019-1026.
3. Stoll BJ, Hansen NI, Bell EF, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039-1051.
4. Kugelman A, Reichman B, Chistyakov I, et al; Israel Neonatal Network. Postdischarge infant mortality among very low-birth weight infants: a population-based study. Pediatrics. 2007;120(4):e788-e794.
5. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003;289(9):1124-1129.
6. Doyle LW, Anderson PJ. Long-term outcomes of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14(6):391-395.
7. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-1729.
8. Finer NN, Carlo WA, Walsh MC, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970-1979.
9. Oncel MY, Arayici S, Uras N, et al. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within theminimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2016;101(4):F323-F328.
10. Kribs A, Roll C, Göpel W, et al; NINSAPP Trial Investigators. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169(8):723-730.
11. Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Noninvasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013;347:f5980.
12. Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: ameta-analysis. Pediatrics. 2013;132(5):e1351-e1360.
13. Isayama T, Chai-Adisaksopha C, McDonald SD. Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: a systematic review and meta-analysis. JAMA Pediatr. 2015;169(8):731-739.
14. Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and networkmeta-analysis. BMJ. 2013;346:f2914.
15. World Health Organization. International Clinical Trials Registry Platform (ICTRP). 2016; http://www.who.int/ictrp/en. Accessed January 2, 2016.
16. Isayama T, Iwami H, McDonald S, Beyene J. Early respiratory management strategies to prevent chronic lung disease in preterm infants with or at risk of respiratory distress syndrome: a systematic review and networkmeta-analysis. http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID =CRD42015023403. Accessed July 13, 2016.
17. Aguar M, Vento M, Dargaville PA. Minimally invasive surfactant therapy: an update. Neoreviews. 2014;15:e275.
18. Kirpalani H, Millar D, Lemyre B, Yoder BA, Chiu A, Roberts RS; NIPPV Study Group. A trial comparing noninvasive ventilation strategies in preterm infants. N Engl JMed. 2013;369(7):611-620.
19. Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics. 2014;133(1):171-174.
20. Sweet DG, Carnielli V, Greisen G, et al; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 update. Neonatology. 2013;103(4):353-368.
21. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines, 2: framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395-400.
22. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr. 1978;92(4):529-534.
23. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3(3):CD000510.
24. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007; (4): CD003063.
25. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7.
26. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991-999.
27. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://handbook.cochrane.org. Accessed January 10, 2016.
28. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105-3124.
29. Mills EJ, Ioannidis JP, Thorlund K, Schünemann HJ, Puhan MA, Guyatt GH. How to use an article reporting a multiple treatment comparison meta-analysis. JAMA. 2012;308(12):1246-1253.
30. Brooks S, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7(4):434-455.
31. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency inmixed treatment comparison meta-analysis. Stat Med. 2010;29(7-8):932-944.
32. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163-171.
33. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
34. Puhan MA, Schünemann HJ, Murad MH, et al; GRADEWorking Group. A GRADEWorking Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2014;349:g5630.
35. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6: rating the quality of evidence-imprecision. J Clin Epidemiol. 2011;64(12):1283-1293.
36. Dupont WD, Plummer WD Jr. Power and sample size calculations: a review and computer program. Control Clin Trials. 1990;11(2):116-128.
37. Dunn MS, Kaempf J, de Klerk A, et al; Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128(5):e1069-e1076.
38. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants >30 weeks' gestation. Pediatrics. 2004;113(6):e560-e563.
39. Huang XL, Chen D, Li XP, Li MY, Shen JF, Wu XS. Clinical effectiveness of INSURE method in the treatment of neonatal respiratory distress syndrome [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15(1):9-13.
40. Nayeri FS, Esmaeilnia Shirvani T, Aminnezhad M, Amini E, Dalili H, Moghimpour Bijani F. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge. Acta Med Iran. 2014;52(8):596-600.
41. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB; COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358(7):700-708.
42. Verder H, Robertson B, Greisen G, et al; Danish-Swedish Multicenter Study Group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331(16):1051-1055.
43. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999;103(2):E24.
44. Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol. 2005;25(11):703-708.
45. Rojas MA, Lozano JM, Rojas MX, et al; Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009;123(1):137-142.
46. Sandri F, Plavka R, Ancora G, et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125(6):e1402-e1409.
47. Kandraju H, Murki S, Subramanian S, Gaddam P, Deorari A, Kumar P. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial. Neonatology. 2013;103(2):148-154.
48. Dilmen U, Özdemir R, Tatar Aksoy H, et al. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study. J Matern Fetal Neonatal Med. 2014;27(4):411-415.
49. Nakhshab M, Tajbakhsh M, Khani S, Farhadi R. Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study. Pediatr Neonatol. 2015;56(2):88-94.
50. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007;150(5):521-526, 526.e1.
51. Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr. 2009;98(9):1412-1415.
52. Lista G, Castoldi F, Fontana P, et al. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomised control trial. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F85-F89.
53. Meneses J, Bhandari V, Alves JG, Herrmann D. Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial. Pediatrics. 2011;127(2):300-307.
54. Kong LK, Kong XY, Li LH, et al. Comparative study on application of duo positive airway pressure and continuous positive airway pressure in preterm neonates with respiratory distress syndrome [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2012;14(12):888-892.
55. Armanian AM, Badiee Z, Heidari G, Feizi A, Salehimehr N. Initial treatment of respiratory distress syndrome with nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure: a randomized controlled trial. Int J Prev Med. 2014;5(12):1543-1551.
56. Aguiar T, Macedo I, Voutsen O, et al. Nasal bilevel vs continuous positive airway pressure in preterm infants: a randomized controlled trial. J Clin Trials. 2015;5(3):221.
57. Salama G, Ayyash F, AI-Rabadi A, Alquran M, Shakkoury A. Nasai-IMV vs Nasai-CPAP as an initial mode of respiratory support for premature infants with RDS: a prospective randomized clinical trial. Rawal Med J. 2015;40(2):197-202.
58. Berggren E, Liljedahl M, Winbladh B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr. 2000;89(4):460-464.
59. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131(2):e502-e509.
60. Mirnia K, Heidarzadeh M, Hosseini MB, Sadeghnia A, Balila M, Ghojazadeh M. Comparison outcome of surfactant administration via tracheal catheterization during spontaneous breathing with INSURE. Med J IslamWorld Acad Sci. 2013;21(4):143-148.
61. Bao Y, Zhang G, Wu M, Ma L, Zhu J. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BMC Pediatr. 2015;15:21.
62. Vaucher YE, Peralta-Carcelen M, Finer NN, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367(26):2495-2504.
63. Pinheiro JM, Santana-Rivas Q, Pezzano C. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. J Perinatol. 2016;36(3):196-201.
64. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: ameta-narrative review. JAMA Pediatr. 2014;168(10):901-908.
65. Kumar P, Denson SE, Mancuso TJ; Committee on Fetus and Newborn, Section on Anesthesiology and Pain Medicine. Premedication for nonemergency endotracheal intubation in the neonate. Pediatrics. 2010;125(3):608-615.
66. Meneses J, Bhandari V, Alves JG. Nasal intermittent positive-pressure ventilation vs nasal continuous positive airway pressure for preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2012;166(4):372-376.
67. Göpel W, Kribs A, Härtel C, et al; German Neonatal Network (GNN). Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr. 2015;104(3):241-246.
68. Brix N, Sellmer A, Jensen MS, Pedersen LV, Henriksen TB. Predictors for an unsuccessful intubation-surfactant-extubation procedure: a cohort study. BMC Pediatr. 2014;14:155.
69. Dargaville PA, Aiyappan A, De Paoli AG, et al. Continuous positive airway pressure failure in preterm infants: incidence, predictors and consequences. Neonatology. 2013;104(1):8-14.
70. Schmidt B, Roberts RS, Davis P, et al; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112-2121.
71. Dargaville PA, Kamlin CO, De Paoli AG, et al. The OPTIMIST-A trial: evaluation ofminimallyinvasive surfactant therapy in preterm infants 25-28 weeks gestation. BMC Pediatr. 2014;14:213.